Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 872188629 | 8721886 | 29 | F | 20120322 | 20160913 | 20120814 | 20160917 | EXP | PHHY2012CA060357 | NOVARTIS | 81.42 | YR | F | Y | 0.00000 | 20160918 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 872188629 | 8721886 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 10 MG, QMO | 21008 | 10 | MG | /month | |||||||
| 872188629 | 8721886 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO | 21008 | 20 | MG | /month | |||||||
| 872188629 | 8721886 | 3 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (EVERY 4 WEEKS) | 21008 | 30 | MG | /month | |||||||
| 872188629 | 8721886 | 4 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | BID | U | 0 | BID | ||||||||
| 872188629 | 8721886 | 5 | SS | COUMADINE | WARFARIN SODIUM | 1 | Unknown | 0 | |||||||||||
| 872188629 | 8721886 | 6 | C | ONGLYZA | SAXAGLIPTIN HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 872188629 | 8721886 | 7 | C | IRON | IRON | 1 | Intravenous (not otherwise specified) | U | 0 | ||||||||||
| 872188629 | 8721886 | 8 | C | FRAGMIN | DALTEPARIN SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 872188629 | 8721886 | 9 | C | CARDIZEM | DILTIAZEM HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 872188629 | 8721886 | 10 | C | ATACAND | CANDESARTAN CILEXETIL | 1 | Unknown | U | 0 | ||||||||||
| 872188629 | 8721886 | 11 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | U | 0 | ||||||||||
| 872188629 | 8721886 | 12 | C | LASIX | FUROSEMIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 872188629 | 8721886 | 1 | Gastrointestinal angiodysplasia haemorrhagic |
| 872188629 | 8721886 | 4 | Gastrointestinal angiodysplasia haemorrhagic |
| 872188629 | 8721886 | 5 | Product used for unknown indication |
| 872188629 | 8721886 | 6 | Product used for unknown indication |
| 872188629 | 8721886 | 7 | Product used for unknown indication |
| 872188629 | 8721886 | 8 | Product used for unknown indication |
| 872188629 | 8721886 | 9 | Product used for unknown indication |
| 872188629 | 8721886 | 10 | Product used for unknown indication |
| 872188629 | 8721886 | 11 | Product used for unknown indication |
| 872188629 | 8721886 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 872188629 | 8721886 | HO |
| 872188629 | 8721886 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 872188629 | 8721886 | Abdominal pain | |
| 872188629 | 8721886 | Anaemia | |
| 872188629 | 8721886 | Asthenia | |
| 872188629 | 8721886 | Blood glucose increased | |
| 872188629 | 8721886 | Blood pressure diastolic decreased | |
| 872188629 | 8721886 | Blood pressure systolic increased | |
| 872188629 | 8721886 | Body temperature decreased | |
| 872188629 | 8721886 | Body temperature increased | |
| 872188629 | 8721886 | Cardiac failure | |
| 872188629 | 8721886 | Dysphonia | |
| 872188629 | 8721886 | Dyspnoea | |
| 872188629 | 8721886 | Eating disorder | |
| 872188629 | 8721886 | Endometrial thickening | |
| 872188629 | 8721886 | Epistaxis | |
| 872188629 | 8721886 | Escherichia infection | |
| 872188629 | 8721886 | Faeces discoloured | |
| 872188629 | 8721886 | Fatigue | |
| 872188629 | 8721886 | Gallbladder enlargement | |
| 872188629 | 8721886 | Headache | |
| 872188629 | 8721886 | Heart rate decreased | |
| 872188629 | 8721886 | Hepatic haematoma | |
| 872188629 | 8721886 | Hyperhidrosis | |
| 872188629 | 8721886 | Infection | |
| 872188629 | 8721886 | Injection site pain | |
| 872188629 | 8721886 | Oxygen saturation decreased | |
| 872188629 | 8721886 | Pleural effusion | |
| 872188629 | 8721886 | Pneumonia | |
| 872188629 | 8721886 | Pollakiuria | |
| 872188629 | 8721886 | Polydipsia | |
| 872188629 | 8721886 | Polyuria | |
| 872188629 | 8721886 | Post procedural bile leak | |
| 872188629 | 8721886 | Product use issue | |
| 872188629 | 8721886 | Productive cough | |
| 872188629 | 8721886 | Pyrexia | |
| 872188629 | 8721886 | Thirst | |
| 872188629 | 8721886 | Type 2 diabetes mellitus | |
| 872188629 | 8721886 | Uterine cancer | |
| 872188629 | 8721886 | Vaginal haemorrhage | |
| 872188629 | 8721886 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 872188629 | 8721886 | 1 | 20120322 | 20120419 | 0 | |
| 872188629 | 8721886 | 2 | 20120517 | 20120809 | 0 | |
| 872188629 | 8721886 | 3 | 20120906 | 0 | ||
| 872188629 | 8721886 | 4 | 201202 | 0 | ||
| 872188629 | 8721886 | 7 | 20120807 | 0 | ||
| 872188629 | 8721886 | 8 | 20141214 | 0 |